Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...

While many report positive results after taking the medication, experts warn significant weight loss can negatively impact ...

On behalf of our sponsors at Dr. Stephanie’s, we’re learning some ways to improve our health and wellness with Dr.

Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...

We recently published a list of 12 Best FMCG Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Mondelez International, Inc.

So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry's latest cancer ...

Among patients with type 2 diabetes, use of GLP-1 agonists may increase the risks for adhesive capsulitis and required ...

Tirzepatide, found in Mounjaro and Zepbound, mimics both GIP and GLP-1 hormones to activate insulin production. Semaglutide, ...

A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

A previous study published in 2024 found that people using semaglutide are four times more likely to develop a rare but scary eye condition called nonarteritic anterior ischemic optic neuropathy, or ...

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.